Anaphylatoxin C3a enhances mucous glycoprotein release from human airways in vitro.
Authors:
- Z MaromZMZ Marom
- J ShelhamerJSJ Shelhamer
- M BergerMBM Berger
- M FrankMFM Frank
- M KalinerMKM Kaliner
Open Access
- 1 April 1985
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 161 (4) , 657-668
Abstract
Because C3a may be generated during the course of pulmonary inflammatory reactions, we investigated the ability of C3a to affect mucous glycoprotein (MGP) secretion from cultured human airways. C3a, but not C3a des Arg, caused a dose-related increase in MGP release (maximal after 4-6 h), with as little as 15 micrograms of C3a per milliliter stimulating a 40% increase. The experimental evidence suggested that immunologically specific C3a was required for the secretagogue actions, as monospecific anti-C3a inhibited the reaction, as well as specifically absorbing the secretagogue from solution. Moreover, it appeared that C3a does not require mast cell activation, eicosanoid generation, or macrophage-derived mucus secretagogue synthesis for its effect, since (a) no evidence of histamine release accompanied C3a-induced MGP release, and dibutyryl cAMP failed to affect C3a-induced MGP release, while reducing the actions of reversed anaphylaxis; (b) MGP release caused by C3a was not influenced by eicosatetraynoic acid or specific cyclooxygenase inhibitors, and no leukotrienes were detectable on the supernatants of C3a-stimulated airways; and (c) cycloheximide failed to affect C3a secretion-stimulating actions. Thus, C3a is a potent mucus secretagogue, and, possibly, acts directly as a glandular stimulant. It seems likely that C3a generated in the course of pulmonary inflammation might contribute to the mucus secretion associated with pulmonary infections.Keywords
This publication has 27 references indexed in Scilit:
- Immunologic and Neuropharmacologic Stimulation of Mucous Glycoprotein Release from Human Airways In VitroJournal of Clinical Investigation, 1980
- Prostaglandins, macrophages, and immunity.The Journal of Immunology, 1980
- MICROPIPET MEASUREMENT OF AIRWAY SUB-MUCOSAL GLAND SECRETION - AUTONOMIC EFFECTS1980
- PULMONARY INJURY INDUCED BY ANAPHYLATOXINS-C3A AND C5A-ANAPHYLATOXINS1980
- Aggregation of Leukocytes Induced by the Complement-Derived Peptides C3a and C5a and by Three Synthetic Formyl-Methionyl PeptidesInternational Archives of Allergy and Immunology, 1980
- SLOW REACTING SUBSTANCE (SRS) FROM IONOPHORE A23187-STIMULATED PERITONEAL MAST-CELLS OF THE NORMAL RAT .2. EVIDENCE FOR A PRECURSOR ROLE OF ARACHIDONIC-ACID AND FURTHER PURIFICATION1979
- A method for preparing IgG F(ab′)2 fragments using small amounts of serumJournal of Immunological Methods, 1976
- Release of histamine from rat mast cells by the complement peptides C3a and C5a.1975
- Cytology of Respiratory Epithelium as a Predictor of Respiratory Complications after OperationChest, 1975
- An Organ Culture Study of the Effect of Drugs on the Secretory Activity of the Human Bronchial Submucosal GlandClinical Science, 1972